Aurinia Pharmaceuticals Inc. AUPH
16.24 USD +0.03 (+0.19%)
Nov 12, 2026, 2:59 PM EST
16.15 Day range 16.44
13.52 52-week range 19.25
- YTD
- +1.82%
- 1 year
- +4.50%
AUPH revenue history
Revenue is income from the company’s ordinary business activities.
283,055,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 283,055,000 | 47,922,000 | 20.38% |
| FY 2024 | 2024-12-31 | 235,133,000 | 59,620,000 | 33.97% |
| FY 2023 | 2023-12-31 | 175,513,000 | 41,483,000 | 30.95% |
| FY 2022 | 2022-12-31 | 134,030,000 | 88,425,000 | 193.89% |
| FY 2021 | 2021-12-31 | 45,605,000 | -4,513,000 | -9.00% |
| FY 2020 | 2020-12-31 | 50,118,000 | 49,800,000 | 15660.38% |
| FY 2019 | 2019-12-31 | 318,000 | -145,000 | -31.32% |
| FY 2018 | 2018-12-31 | 463,000 | 45,000 | 10.77% |
| FY 2017 | 2017-12-31 | 418,000 | 245,000 | 141.62% |
| FY 2016 | 2016-12-31 | 173,000 | -62,000 | -26.38% |
| FY 2015 | 2015-12-31 | 235,000 | -43,000 | -15.47% |
| FY 2014 | 2014-12-31 | 278,000 | -691,000 | -71.31% |
| FY 2013 | 2013-12-31 | 969,000 | -5,157,000 | -84.18% |
| FY 2012 | 2012-12-31 | 6,126,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-09T06:01:37.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.